Substance P (9-11)

CAS No. 4652-64-6

Substance P (9-11)( ——— )

Catalog No. M41625 CAS No. 4652-64-6

Gly-Leu-Met-NH2 is a C-terminal tripeptide of Substance P (Substance P ). Substance P is a neuropeptide.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 89 Get Quote
10MG 131 Get Quote
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Substance P (9-11)
  • Note
    Research use only, not for human use.
  • Brief Description
    Gly-Leu-Met-NH2 is a C-terminal tripeptide of Substance P (Substance P ). Substance P is a neuropeptide.
  • Description
    Gly-Leu-Met-NH2 is a C-terminal tripeptide of Substance P (Substance P ). Substance P is a neuropeptide.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    4652-64-6
  • Formula Weight
    318.44
  • Molecular Formula
    C13H26N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sandrine Sagan, et al. Conformational analysis of the C-terminal Gly-Leu-Met-NH2 tripeptide of substance P bound to the NK-1 receptor. Chem Biol. 2005 May;12(5):555-65. ?
molnova catalog
related products
  • Zoliflodacin (b)

    Zoliflodacin?is a new antibiotic that inhibits DNA biosynthesis.

  • Diaveridine

    Diaveridine (DVD) is a popular antibacterial synergist that is widely used in combination with sulfonamide.

  • Tricine

    Tricine can clearly visualize tumors, may as melanoma imaging agents. Using the combination of tricine and a phosphine ligand, HYNIC-derivatized peptides or other small molecules can be labeled with 99mTc in high specific activity and with high stability for potential use as radiopharmaceuticals.